SOADOR
MED icon

State of Alaska Department of Revenue’s Medifast MED Stock Holding History

State of Alaska Department of Revenue’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,566
Closed -$251K – 1611
2024
Q1 		$251K Sell
6,566
-136
-2% -$6.59K ﹤0.01% 1557
2023
Q4 		$450K Sell
6,702
-78
-1% -$5.43K 0.01% 1418
2023
Q3 		$507K Sell
6,780
-385
-5% -$34.2K 0.01% 1315
2023
Q2 		$660K Sell
7,165
-319
-4% -$28.4K 0.01% 1219
2023
Q1 		$775K Sell
7,484
-125
-2% -$13.9K 0.01% 1123
2022
Q4 		$877K Sell
7,609
-27
-0.4% -$3.14K 0.01% 1045
2022
Q3 		$827K Sell
7,636
-1,068
-12% -$153K 0.01% 1025
2022
Q2 		$1.57M Buy
8,704
+605
+7% +$108K 0.02% 744
2022
Q1 		$1.38M Sell
8,099
-130
-2% -$24.5K 0.01% 822
2021
Q4 		$1.72M Sell
8,229
-330
-4% -$68.2K 0.02% 788
2021
Q3 		$1.65M Buy
8,559
+426
+5% +$105K 0.02% 808
2021
Q2 		$2.3M Buy
8,133
+160
+2% +$43.4K 0.02% 629
2021
Q1 		$1.69M Sell
7,973
-1,180
-13% -$282K 0.02% 752
2020
Q4 		$1.8M Sell
9,153
-1,857
-17% -$328K 0.02% 664
2020
Q3 		$1.81M Sell
11,010
-100
-0.9% -$16.5K 0.02% 603
2020
Q2 		$1.54M Buy
11,110
+340
+3% +$31.2K 0.02% 675
2020
Q1 		$673K Buy
10,770
+1,995
+23% +$182K 0.01% 957
2019
Q4 		$961K Sell
8,775
-320
-4% -$31K 0.01% 927
2019
Q3 		$942K Buy
9,095
+5,043
+124% +$542K 0.01% 891
2019
Q2 		$519K Buy
4,052
+52
+1% +$7.22K 0.01% 1039
2019
Q1 		$510K Sell
4,000
-5
-0.1% -$634 0.01% 1049
2018
Q4 		$500K Buy
4,005
+132
+3% +$22.6K 0.01% 965
2018
Q3 		$858K Buy
3,873
+400
+12% +$81.1K 0.01% 805
2018
Q2 		$556K Buy
3,473
+90
+3% +$11.5K 0.01% 1013
2018
Q1 		$316K Buy
3,383
+1,285
+61% +$96K 0.01% 1213
2017
Q4 		$146K Sell
2,098
-120
-5% -$7.96K ﹤0.01% 1409
2017
Q3 		$131K Hold
2,218
– – 0.01% 1122
2017
Q2 		$91K Buy
2,218
+988
+80% +$42.9K 0.01% 1122
2017
Q1 		$54K Buy
1,230
+20
+2% +$861 ﹤0.01% 1102
2016
Q4 		$50K Buy
+1,210
New +$48.7K ﹤0.01% 838

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State of Alaska Department of Revenue's MED Position: Q2 2024 in Review

State of Alaska Department of Revenue sold out of Medifast (MED) in Q2 2024, closing a stake of 6,566 shares — an estimated $251K sold.

State of Alaska Department of Revenue first reported a position in MED in Q4 2016 and held it in 30 quarters. The position peaked at $2.3M in Q2 2021. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • State of Alaska Department of Revenue reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • State of Alaska Department of Revenue sold 6,566 Medifast shares in Q2 2024, an estimated $251K.
  • State of Alaska Department of Revenue first reported a position in Medifast in Q4 2016 and held it in 30 quarters.
  • State of Alaska Department of Revenue's Medifast position peaked at $2.3M in Q2 2021.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2024, filed 5 Aug 2024.